Education
About Us
Working with TipRanks
Follow Us
China Resources Pharmaceutical Group Ltd. (DE:640)
:640
Summary of all the Indicators
Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
China Resources Pharmaceutical Group Ltd.’s (640) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting China Resources Pharmaceutical Group Ltd. is a Buy.
China Resources Pharmaceutical Group Ltd.’s (640) 20-Day exponential moving average is 0.63, while China Resources Pharmaceutical Group Ltd.’s (640) share price is €0.66, making it a Buy.
China Resources Pharmaceutical Group Ltd.’s (640) 50-Day exponential moving average is 0.63, while China Resources Pharmaceutical Group Ltd.’s (640) share price is €0.66, making it a Buy.
China Resources Pharmaceutical Group Ltd. (640) Pivot Points
Classic
0.60
0.60
0.60
0.60
0.60
0.60
0.60
Fibonacci
0.60
0.60
0.60
0.60
0.60
0.60
0.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
China Resources Pharmaceutical Group Ltd. (640) Moving Averages
MA5
0.62Buy
0.63Buy
MA10
0.62Buy
0.63Buy
MA20
0.64Buy
0.63Buy
MA50
0.63Buy
0.63Buy
MA100
0.64Buy
0.64Buy
MA200
0.64Buy
0.63Buy
China Resources Pharmaceutical Group Ltd.’s (640) 10-Day exponential moving average is 0.63, while China Resources Pharmaceutical Group Ltd.’s (640) share price is €0.66, making it a Buy.
China Resources Pharmaceutical Group Ltd.’s (640) 100-Day exponential moving average is 0.64, while China Resources Pharmaceutical Group Ltd.’s (640) share price is €0.66, making it a Buy.
China Resources Pharmaceutical Group Ltd.’s (640) stock price is €0.66 and China Resources Pharmaceutical Group Ltd.’s (640) 50-day simple moving average is 0.63, creating a Buy signal.
China Resources Pharmaceutical Group Ltd.’s (640) stock price is €0.66 and China Resources Pharmaceutical Group Ltd.’s (640) 100-day simple moving average is 0.64, creating a Buy signal.
China Resources Pharmaceutical Group Ltd.’s (640) stock price is €0.66 and China Resources Pharmaceutical Group Ltd.’s (640) 200-day simple moving average is 0.64, creating a Buy signal.
China Resources Pharmaceutical Group Ltd. (640) Technical Indicators
RSI (14)
60.26
Neutral
STOCH (9,6)
36.36
Neutral
STOCHRSI (14)
36.36
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
21.14
Neutral
Williams %R
9.09
Sell
CCI (14)
48.84
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
61.82
Neutral
ROC
1.54
Buy
China Resources Pharmaceutical Group Ltd.’s (640) Relative Strength Index (RSI) is 60.26, creating a Neutral signal.
China Resources Pharmaceutical Group Ltd.’s (640) Trend Strength Indicator (ADX) is 21.14, creating a Neutral signal.
China Resources Pharmaceutical Group Ltd.’s (640) Commodity Channel Index (CCI) is 48.84, creating a Neutral signal.
China Resources Pharmaceutical Group Ltd.’s (640) Price Rate of Change (ROC) is 1.54, creating a Buy signal.
FAQ
Is 640 a Buy, Hold, or Sell?
Based on 640’s technical indicators, 640 is a Strong Buy.
What is 640’s RSI (14)?
640’s RSI (14) is 60.26, which suggests 640 is a Neutral.
What is 640’s MACD?
640’s MACD is >-0.01, which suggests 640 is a Buy.
What is 640’s 5-day moving average?
640’s 5-day moving average is 0.62, which suggests 640 is a Buy.
What is 640’s 20-day moving average?
640 20-day moving average is 0.64, which suggests 640 is a Buy.
What is 640’s 50-day moving average?
640’s 50-day moving average is 0.63, which suggests 640 is a Buy.
What is 640’s 200-day moving average?
640’s 200-day moving average is 0.64, which suggests 640 is a Buy.
What is 640’s Williams % R (14)?
640’s Williams % R (14) is 9.09, which suggests 640 is a Sell.
What is 640’s CCI (14)?
640’s CCI (14) is 48.84, which suggests 640 is a Neutral.
What is the share price of China Resources Pharmaceutical Group Ltd.?